Welcome to our dedicated page for Churchill Cap X news (Ticker: CCCX), a resource for investors and traders seeking the latest updates and insights on Churchill Cap X stock.
News related to Churchill Capital Corp X (NASDAQ: CCCX) focuses heavily on its role as a blank check company pursuing a business combination with ColdQuanta, Inc., known in press releases as Infleqtion. Because Churchill Capital Corp X is a special purpose acquisition company, its news flow is closely tied to transaction milestones, regulatory filings, and joint announcements with its proposed merger partner.
Recent releases describe the filing of a joint registration statement on Form S-4 with the U.S. Securities and Exchange Commission in connection with the proposed business combination. These communications explain that the Form S-4 includes a preliminary proxy statement/prospectus for Churchill Capital Corp X shareholders and outline the process for soliciting proxies and holding a shareholder vote on the transaction.
Many CCCX news items are joint announcements with Infleqtion. They reference Infleqtion’s plans to go public through a merger with Churchill Capital Corp X and describe the expected structure of the combined company, including that it is anticipated to operate as “Infleqtion, Inc.” and to be listed under the ticker “INFQ” upon closing, subject to approvals and customary conditions. These releases also highlight Infleqtion’s activities in neutral-atom quantum technology, such as quantum computing and precision sensing, as context for the proposed transaction.
Investors following CCCX news can use this page to monitor updates on the Merger Agreement, SEC review of the registration statement, proxy materials, and other disclosures connected to the business combination process. Because forward-looking statements and risk factors are a recurring theme in these communications, readers are frequently directed to Churchill Capital Corp X’s SEC filings for more detailed information.
Bookmark this news feed to track ongoing announcements about Churchill Capital Corp X, its proposed merger with Infleqtion, and key regulatory and shareholder milestones that may affect CCCX and any future combined company.
Infleqtion (merging with Churchill Capital Corp X, NASDAQ: CCCX) announced a strategic partnership with Silicon Light Machines to explore integrating SLM’s silicon-germanium MEMS Displacement Phase Modulator (DPM™) into Infleqtion’s neutral atom quantum computers.
The collaboration aims to enable faster phase modulation for individual qubit addressing, optical multiplexing, and scalable laser processing, supporting Infleqtion’s integrated photonics strategy for miniaturization, cost reduction, and improved operating speed to reduce application runtimes.
Infleqtion, a leading quantum technology company, announced a merger with Churchill Capital Corp X (NASDAQ: CCCX) to go public under the ticker "INFQ". The deal values Infleqtion at a $1.8 billion pre-money equity value and is expected to provide over $540 million in gross proceeds, including a $125 million PIPE investment from notable investors.
The company specializes in neutral atom-based quantum technology, generating $29 million in trailing twelve-month revenue as of June 2025, with $50 million in booked business and a $300+ million pipeline. Infleqtion has achieved significant technical milestones, including 1,600 physical qubits and 99.73% entangling fidelity, and serves major clients like NVIDIA, NASA, and the U.S. Department of Defense.